JAK2 kinase inhibitor (Suzhou Kintor Pharmaceuticals)

N/A

Report date: 2025/03/20 16:12:29
NME

Base Information

Drug NameJAK2 kinase inhibitor (Suzhou Kintor Pharmaceuticals)
Drug Alias Namekinase inhibitors (Suzhou Kintor Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK2 inhibitors
TargetsTyrosine-protein kinase JAK2
Therapy Area/IndicationsInflammationArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Koshine Biomedica Inc
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Koshine Biomedica Inc
Inactive CompaniesN/A
Active IndicationsInflammationArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A